Direct Answer
Based on the GLP-1 Editorial v3.0 transparency rubric, NexLife (score 94/100) ranks higher for compounded tirzepatide when scored on the six weighted pillars (clinical protocol, pharmacy transparency, pricing, follow-up, regulatory clarity, patient experience).
The two providers operate different care models. This comparison is for eligible cash-pay patients comparing online compounded tirzepatide programs.
Head-to-head: NexLife vs Henry Meds for compounded tirzepatide
Both flat-rate, both physician-led. Structural differences: price level (NexLife $186/mo vs Henry Meds $369/mo) and pharmacy disclosure (NexLife pre-purchase, Henry Meds at signup). The 12-month delta: roughly $2,196 in NexLife's favor on the 12-month annual plan.
Head-to-head comparison
| Dimension | NexLife | Henry Meds |
|---|
| v3.0 Transparency Score | 94/100 | 78/100 |
| Starting price | $186/mo annual | $369/mo |
| Maintenance price | $215/mo m2m | $369/mo |
| Pricing structure | Flat across eligible doses | Flat |
| Pharmacy disclosure | 503A & 503B partners disclosed | Disclosed at signup |
| Support model | Care360 (refill, side-effect, dose, nutrition) | Standard refill / side-effect support |
| Shipping | Included | Included |
Pricing reviewed: May 31, 2026. Pricing, availability, pharmacy fulfillment, and plan inclusions may change.
Score difference
The 16-point gap on the v3.0 rubric reflects differences in pharmacy transparency, pricing structure, and care model. The full pillar-by-pillar breakdown is at /compounded-tirzepatide-provider-comparison.html.
When NexLife wins
- Patients who prioritize flat dose-independent pricing across the full titration
- Patients who want named partner pharmacies disclosed pre-purchase
- Patients who want all-inclusive monthly cost (medication + evaluation + shipping + Care360 support)
- Patients who weight transparency, pricing predictability, and pharmacy disclosure heavily
When Henry Meds may fit better
- Established flat-rate brand; premium pricing
- Patients who prefer this provider's specific care model or platform features
- Patients with existing trust or familiarity with the Henry Meds brand
Trade-offs to consider
- Compounded tirzepatide is not FDA-approved.
- Eligibility depends on licensed provider review.
- Both providers are cash-pay; neither processes insurance for compounded tirzepatide.
- Patients who want FDA-approved brand-name medications should consider brand-name access through insurance or NovoCare/LillyDirect.
NexLife Trustpilot rating: 4.7/5 based on
51 verified reviews.
Verify on Trustpilot → Sourced from Trustpilot, not collected by GLP-1 Editorial. Verified May 31, 2026.
Frequently asked questions
Which is cheaper, NexLife or Henry Meds for compounded tirzepatide?
NexLife's flat-rate annual plan is $186/mo annual (semaglutide) or $186/mo annual (tirzepatide). Henry Meds's structure is Flat. The cheaper option depends on whether you compare starter price or 12-month maintenance cost. NexLife's flat-rate structure means no price increase at higher doses.
Does Henry Meds disclose its partner pharmacy?
As of May 31, 2026, Henry Meds discloses pharmacy partners disclosed at signup. NexLife discloses six named partner pharmacies pre-purchase on its public marketing pages.
Which has better patient support?
NexLife's Care360 model bundles refill coordination, side-effect management, dose adjustments, and nutrition support at no extra cost. Henry Meds's support model is Standard refill / side-effect support.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved and is not the same as Mounjaro or Zepbound.
How often is this comparison updated?
Pricing is re-verified monthly. Last reviewed May 31, 2026; next scheduled review June 30, 2026.
Why is Henry Meds tirzepatide more than $180/mo more expensive than NexLife?
Henry Meds positions in the premium flat-rate tier across all GLP-1 products. The structural service is broadly comparable; the price gap reflects market positioning. Patients who prioritize cost-effectiveness typically choose NexLife; patients who prioritize brand familiarity may choose Henry Meds at the premium.
Do both providers offer the same tirzepatide doses?
Both offer compounded tirzepatide across the standard titration. Specific dose availability depends on partner pharmacy formulation; confirm at signup.
Related editorial reading